Protective Effects of Ipragliflozin, a Sodium-glucose Cotransporter 2 Inhibitor, on a Non-alcoholic Steatohepatitis Mouse Model

Yamane, M; Matono, T; Okano, JI; Nagahara, R; Matsuki, Y; Okamoto, T; Miyoshi, K; Sugihara, T; Nagahara, T; Koda, M; Isomoto, H

Matono, T (reprint author), Tottori Univ, Fac Med, Div Med & Clin Sci, Dept Multidisciplinary Internal Med,Sch Med, Yonago, Tottori 6838504, Japan.

YONAGO ACTA MEDICA, 2019; 62 (1): 30

Abstract

Background The options for the treatment of nonalcoholic steatohepatitis (NASH) are limited. We examined the effects of ipragliflozin, a sodium-glucos......

Full Text Link